Yeah, seems like a non-issue.
I wish they would double the cost and recommend a two-shot series of boosters in future, just to see whether it helps significantly with efficacy. Also, pick the right darn candidate for the virus. Hopefully they'll pick Flirt or whatever this year, but even...